Stay updated on Dexmedetomidine for Schizophrenia Agitation Clinical Trial
Sign up to get notified when there's something new on the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page.

Latest updates to the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page
- CheckyesterdayChange DetectedThe site footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe site revision identifier changes from v3.7.2 to v3.8.0, while the study record content remains unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedA notice announces NIH website updates and explains that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference0.7%

- Check36 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check43 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry labeled v3.7.0 was added to the study history, and the previously listed revision v3.6.6 was removed from the history view.SummaryDifference0.1%

Stay in the know with updates to Dexmedetomidine for Schizophrenia Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dexmedetomidine for Schizophrenia Agitation Clinical Trial page.